Key result
Higher admission random blood glucose linked to increased 90-day all-cause mortality in AMI patients.
Why the study?
Assessment of prognostic markers is essential to determine adverse outcomes in AMI, leading investigators to examine the role of random blood glucose for assessing AMI severity.
Population
79 patients with onset symptoms of AMI
Comparison
Random blood glucose levels
Design
Prospective study
Follow-up
Day 90
Authors
Loading...
Admission hyperglycemia may aid risk stratification in AMI; leaves open whether targeted intervention improves survival.
Cohort (n=79)
No
p-value: p=0.05
Hyperglycemia on admission in patients with acute myocardial infarction is significantly associated with an increased risk of 90-day mortality.
Jain et al. (2019) conducted a cohort in Acute myocardial infarction (n=79). Random blood glucose on admission vs. Lower blood glucose levels was evaluated on All-cause mortality at 90 days (p=0.05). Higher random blood glucose on admission was significantly associated with increased 90-day all-cause mortality in patients with acute myocardial infarction (p=0.05).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: